Investors Watch List: CorMedix (NYSEMKT:CRMD), Wells Fargo & Company (NYSE:WFC), AptarGroup (NYSE:ATR), AbbVie Inc. (NYSE:ABBV), Panera Bread Company (NASDAQ:PNRA)


On Thursday shares of CorMedix, Inc. (NYSEMKT:CRMD) closed at $7.50. On April 23, CorMedix Inc. (NYSEMKT:CRMD), announced presentations on Neutrolin® post marketing surveillance data at the 9th Congress of Vascular Access Society in Barcelona and the National Kidney Foundation Spring Clinical Meeting in Dallas.

Wells Fargo & Company (NYSE:WFC) in last trading activity decreased -0.65% to close at $55.10. Company weekly performance is 0.44% while its quarterly performance stands at 5.12%. Wells Fargo & Company (NYSE:WFC) is -2.11% away from its 52 week high. Wells Fargo & Company (NYSE:WFC), NeighborWorks America® and its network members Self-Help Enterprises and NeighborWorks Homeownership Center Sacramento Region announced the $7.5 million Wells Fargo HomeLIFT℠ program for Fresno, Modesto and Stockton.

On Thursday shares of AptarGroup, Inc. (NYSE:ATR) closed at $62.07. Company’s sales growth for last 5 years was 7.10% and EPS growth for next 5 years is recorded as 8.49%. AptarGroup Inc (NYSE:ATR), Thursday reported first-quarter net income of $45.1 million or $0.70 per share, down from $48.4 million or $0.71 per share last year.

AbbVie Inc. (NYSE:ABBV) has 0.10% insider ownership while its institutional ownership stands at 73.20%. In last trading activity company’s stock closed at $64.66. BMO Capital Markets reissued their outperform rating on shares of AbbVie (NASDAQ:ABBV) in a research report released on Monday morning. BMO Capital Markets currently has a $68.00 price objective on the stock.

On last trading day Panera Bread Company (NASDAQ:PNRA) decreased -1.04% to close at $182.48. Its volatility for the week is 1.82% while volatility for the month is 1.74%. PNRA’s sales growth for past 5 years was 13.30% and its EPS growth for past 5 years was 19.00%. Panera Bread Company (NASDAQ:PNRA) monthly performance is 14.05%. On April 28, Panera Bread Company (NASDAQ:PNRA) reported net income of $32 million, or $1.20 per diluted share, for fiscal Q1 2015. Diluted EPS for fiscal Q1 2015 was $1.41 or down 9%, excluding charges recorded in fiscal Q1 2015 related to the Company’s refranchising initiative of $8.9 million, $5.6 million after-tax, or $0.21 per diluted share.


Leave a Reply

Your email address will not be published. Required fields are marked *